Karotid Cisim Tümörü: Olgu Sunumu

Yıl 2020, Cilt: 7 Sayı: 1, 50 - 53, 28.04.2020

Serkan Yazman Buğra Harmandar , Burak Can Depboylu , Kadir Arslan Serkan Yaşar Çelik

Öz

Karotid cisim tümörleri, nöral krest hücrelerinden kaynaklanan nadir vasküler nöro-endokrin tümörlerdir. En sık baş boyun lokalizasyonunda olmakla birlikte vücudun farklı bölgelerinde de yerleşim gösterebilirler. Tüm baş boyun bölgesi tümörleri içinde % 0.6 oranında görülür ve %10 oranında otozomal dominant ailesel geçiş gösterirler. Genellikle tek taraflı yerleşim gösteren benign tümörler olmalarına karşın %3 oranında malign potansiyelleri de mevcuttur. Asemptomatik, yavaş büyüyen tümörlerdir. Ancak semptomatik hale geldiklerinde, komşu vasküler, nöral dokulara invazyon ve/veya bası yaptıklarında cerrahi olarak eksize edilmeleri gerekmektedir. Cerrahi eksizyonları Shamblin sınıflaması dikkate alınarak yapılır. Burada, Shamblin Tip II karotis cisim tümörlü olguda cerrahi stratejimiz ve operasyon sonuçları sunulmuştur.

---

Anahtar Kelimeler

Cerrahi Sonuçlar, Karotis Cisim Tümörü, Nörolojik Komplikasyon, Vasküler Komplikasyon

Carotid Body Tumor: Case Report

Öz

Carotid body tumors are vascular-neuroendocrine tumors which caused by neural crest cells and are seen rarely. They are usually seen in the head neck localization but may also be located in different parts of the body. They take 0.6 % of all the head and neck tumors and show autosomal dominant familial transition of 10%. Although they are usually unilateral benign tumors, they have 3% malignant potential. They are asymptomatic, slow growing tumors. However, they must be surgically excised when they become symptomatic, invade and / or compress the nearby vascular and neural tissues. Their surgical excision are performed by considering the Shambin classification. Here, we present our surgical strategy and operation results in a case with Shamblin Type II carotid body tumor.

Anahtar Kelimeler

Carotid Body Tumor, Surgical Outcomes, Neural Complication, Vascular Complication

Kaynakça

• 1. Mendenhall WM, Amdur RJ, Vaysberg M, Mendenhall CM, Werning JW. Head and neck paragangliomas. Head Neck. 2011;33:1530-34.
• 2. Lee JH, Barich F, Karnell LH, et al. American College of Surgeons Commission on Cancer; American Cancer Society: National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer. 2002;94:730-7.
• 3. Fruhmann J, Geigl JB, Konstantiniuk P, Cohnert TU. Paraganglioma of the carotid body: treatment strategy and SDH-gene mutations. Eur J Vasc Endovasc Surg. 2013;45(5):431-6.
• 4. Shamblin WR, Remine WH, Sheps SG. Carotid body tumor (chemodectoma). Clinicopathologic analisys of 90 cases. Am J Surg. 1971;122:732-9.
• 5. Ropper AH, Brown RH. Carotid Body Tumor (Paraganglioma). In: Adams and Victor’s Principles of Neurology. 8th ed. McGraw Hill, New York, 2005: 574.
• 6. Budincevic H, Piršic A, BohmT, et al. Carotid body tumor as a cause of stroke. Intern Med. 2016;55(3):295-8.
• 7. Sanlı A, Oz K, Ayduran E, et al. Carotid body tumors and our surgical approaches. Indian J Otolaryngol Head Neck Surg. 2012; 64:158-61.
• 8. Abdelhady K, Durgam S, Orza D, Massad MG. Left atrial and carotid body paraganglioma. Ann Thorac Surg. 2017;103(4):323-5.
• 9. Power AH, Bower TC, Kasperbauer J, et al. Impact of preoperative embolization on outcomes of carotid body tumor resections. J Vasc Surg. 2012;56(4):979-89.
• 10. Cobb AN, Barkat A, Daungjaiboon W, et al. Carotid body tumor resection: Just as safe without preoperative embolization. Ann Vasc Surg. 2018;46:54-9.
• 11. Davila VJ, Chang JM, Stone WM, et al. Current surgical management of carotid body tumors. 2016;64(6):1703-10.
• 12. Amato B, Serra R, Fappiano F, Rossi R, et al. Surgical complications of carotid body tumors surgery: a review. Int Angiol. 2015;34(6 Suppl 1):15-22.